Vertex Pharmaceuticals Inc. buy melinda
Start price
03.03.11
/
50%
€35.24
Target price
05.09.11
€38.00
Performance (%)
-8.91%
End price
05.09.11
€32.10
Summary
This prediction ended on 05.09.11 with a price of €32.10. With a performance of -8.91%, the BUY prediction for Vertex Pharmaceuticals Inc. by melinda closed slightly in the red. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Vertex Pharmaceuticals Inc. | 0.311% | 0.311% | 22.538% | 105.886% |
iShares Core DAX® | 1.051% | -1.833% | 12.822% | 15.392% |
iShares Nasdaq 100 | -0.547% | -3.738% | 40.625% | 42.396% |
iShares Nikkei 225® | -1.778% | -8.115% | 16.092% | 0.891% |
iShares S&P 500 | 0.002% | -2.226% | 28.387% | 41.095% |
According to melinda what are the pros and cons of Vertex Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
HEPATITIS / C
Vertex Pharmaceuticals gab am 2011.02.03 die positiven Ergebnisse der Phase-2-Daten aus der ersten Studie zu Telaprevir in Menschen mit Hepatitis C und HIV-Koinfektion
(Laufzeit überschritten)
Stopped prediction by melinda for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€158.36
17.06.21
17.06.21
€165.00
17.06.22
17.06.22
59.60%
18.06.22
18.06.22
Could be worthwhile Investment >10% per year
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€178.02
29.10.19
29.10.19
€190.00
04.11.21
04.11.21
-11.04%
17.06.21
17.06.21
Could be worthwhile Investment >10% per year
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€134.04
28.09.17
28.09.17
€144.32
05.02.18
05.02.18
9.74%
05.02.18
05.02.18
Could be worthwhile Investment >10% per year
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€77.35
26.01.17
26.01.17
€81.18
28.02.17
28.02.17
5.01%
28.02.17
28.02.17
Could be worthwhile Investment >10% per year
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€55.21
24.09.13
24.09.13
€58.00
24.03.14
24.03.14
-2.54%
24.03.14
24.03.14
Could be worthwhile Investment >10% per year